BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 36518725)

  • 1. Percutaneous Left Atrial Appendage Closure With a Novel LAA Occluder for Stroke Prevention in Atrial Fibrillation.
    Zhang X; Hou S; Liu W; Chen W; Chen F; Ma W; Wang J; Fan Y; Wang Y; Chang D; Fu H; Cai H; Zhang Y; Hou CR; Xu Y; Zhou D; Ge J
    JACC Asia; 2022 Oct; 2(5):547-556. PubMed ID: 36518725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial.
    Holmes DR; Kar S; Price MJ; Whisenant B; Sievert H; Doshi SK; Huber K; Reddy VY
    J Am Coll Cardiol; 2014 Jul; 64(1):1-12. PubMed ID: 24998121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Safety of the WATCHMAN Left Atrial Appendage System for Stroke Prevention in Chinese Patients with Nonvalvular Atrial Fibrillation: A Single-center, Prospective, Observational Study.
    Huang WP; Zhang YH; He L; Su X; Yang XW; Guo ZX
    Chin Med J (Engl); 2017 Feb; 130(4):434-438. PubMed ID: 28218217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Safety and Efficacy in Continued Access Left Atrial Appendage Closure Registries.
    Holmes DR; Reddy VY; Gordon NT; Delurgio D; Doshi SK; Desai AJ; Stone JE; Kar S
    J Am Coll Cardiol; 2019 Dec; 74(23):2878-2889. PubMed ID: 31806131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous WATCHMAN Left Atrial Appendage Closure for Japanese Patients With Nonvalvular Atrial Fibrillation at Increased Risk of Thromboembolism - First Results From the SALUTE Trial.
    Aonuma K; Yamasaki H; Nakamura M; Ootomo T; Takayama M; Ando K; Hirao K; Morino Y; Hayashida K; Kusano K; Main ML; Saito S
    Circ J; 2018 Nov; 82(12):2946-2953. PubMed ID: 30305484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology).
    Reddy VY; Möbius-Winkler S; Miller MA; Neuzil P; Schuler G; Wiebe J; Sick P; Sievert H
    J Am Coll Cardiol; 2013 Jun; 61(25):2551-6. PubMed ID: 23583249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left atrial appendage closure followed by 6 weeks of antithrombotic therapy: a prospective single-center experience.
    Chun KR; Bordignon S; Urban V; Perrotta L; Dugo D; Fürnkranz A; Nowak B; Schmidt B
    Heart Rhythm; 2013 Dec; 10(12):1792-9. PubMed ID: 23973952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous left atrial appendage closure with SeaLA device in non-valvular atrial fibrillation.
    Wang Z; Chu H; Chen X; Tao L; Yuan Y; Ru L; Wang J; Fan Y; Hu H; Wang C; Chen M; Huang W; Zhou D; Liu X; Liang M; Liu J; Han Y
    Catheter Cardiovasc Interv; 2024 Jun; ():. PubMed ID: 38841867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudy.
    Viles-Gonzalez JF; Kar S; Douglas P; Dukkipati S; Feldman T; Horton R; Holmes D; Reddy VY
    J Am Coll Cardiol; 2012 Mar; 59(10):923-9. PubMed ID: 22381428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): A Randomized, Controlled Trial.
    Lakkireddy D; Thaler D; Ellis CR; Swarup V; Sondergaard L; Carroll J; Gold MR; Hermiller J; Diener HC; Schmidt B; MacDonald L; Mansour M; Maini B; O'Brien L; Windecker S
    Circulation; 2021 Nov; 144(19):1543-1552. PubMed ID: 34459659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Device-Related Thrombus After Left Atrial Appendage Closure: Incidence, Predictors, and Outcomes.
    Dukkipati SR; Kar S; Holmes DR; Doshi SK; Swarup V; Gibson DN; Maini B; Gordon NT; Main ML; Reddy VY
    Circulation; 2018 Aug; 138(9):874-885. PubMed ID: 29752398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Device-Related Thrombosis After Percutaneous Left Atrial Appendage Occlusion for Atrial Fibrillation.
    Fauchier L; Cinaud A; Brigadeau F; Lepillier A; Pierre B; Abbey S; Fatemi M; Franceschi F; Guedeney P; Jacon P; Paziaud O; Venier S; Deharo JC; Gras D; Klug D; Mansourati J; Montalescot G; Piot O; Defaye P
    J Am Coll Cardiol; 2018 Apr; 71(14):1528-1536. PubMed ID: 29622159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Assessment of Percutaneous Left-Atrial Appendage Occlusion (LAAO) Devices-A Single Center Cohort Study.
    Kayvanpour E; Kothe M; Kaya Z; Pleger S; Frey N; Meder B; Sedaghat-Hamedani F
    J Cardiovasc Dev Dis; 2024 May; 11(6):. PubMed ID: 38921657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcatheter Left Atrial Appendage Exclusion: Preclinical and Early Clinical Results With the Laminar Device.
    Wong GX; Kar S; Smith TW; Spangler T; Bolling SF; Rogers JH
    JACC Cardiovasc Interv; 2023 Jun; 16(11):1347-1357. PubMed ID: 37294221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of Amulet Left Atrial Appendage Occluder and Watchman Device for Left Atrial Appendage Closure in Patients With Atrial Fibrillation.
    Sawaya F; Abi-Saleh B; Hoteit A; Jdaidany J; Moumneh MB; Harbieh B; Khoury M; Aramouni S; Abdulhai F; Refaat M
    Cureus; 2024 Mar; 16(3):e55531. PubMed ID: 38576630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex Differences in the Combined Ablation and Left Atrial Appendage Closure: Results From LAACablation Registry.
    Chen M; Sun J; Li W; Zhang PP; Zhang R; Mo BF; Yang M; Wang QS; Li YG
    JACC Asia; 2023 Feb; 3(1):138-149. PubMed ID: 36873751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials.
    Reddy VY; Doshi SK; Kar S; Gibson DN; Price MJ; Huber K; Horton RP; Buchbinder M; Neuzil P; Gordon NT; Holmes DR;
    J Am Coll Cardiol; 2017 Dec; 70(24):2964-2975. PubMed ID: 29103847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left Atrial Appendage Occlusion in Patients With Thrombus in Left Atrial Appendage.
    Sahiner L; Coteli C; Kaya EB; Ates A; Kilic GS; Yorgun H; Aytemir K
    J Invasive Cardiol; 2020 Jun; 32(6):222-227. PubMed ID: 32330118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Peridevice Leak on 5-Year Outcomes After Left Atrial Appendage Closure.
    Dukkipati SR; Holmes DR; Doshi SK; Kar S; Singh SM; Gibson D; Price MJ; Natale A; Mansour M; Sievert H; Houle VM; Allocco DJ; Reddy VY
    J Am Coll Cardiol; 2022 Aug; 80(5):469-483. PubMed ID: 35902169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Safety and efficacy of left atrial appendage closure combined with patent foramen ovale closure for atrial fibrillation patients with patent foramen ovale].
    Zhao ZH; Song X; Wang SH; Luo J; Wu YB; Zhu Q; Fang M; Huan Q; Zhang XG; Tian B; Gu W; Zhu LN; Hao SW; Ning ZP
    Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Mar; 50(3):257-262. PubMed ID: 35340144
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.